Inoviv is a startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
Based in the United Kingdom, Inoviv is a startup. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Inoviv provides pre-validated, fully calibrated custom multiplexed LC-MS biomarker panels for an array of diseases, accelerating drug development and reducing risk with rapid, robust biomarker analysis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.